Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term follow-up of autoimmune polyendocrine syndrome type 1 in Norway.

The Journal of clinical endocrinology and metabolism·2026
Same author

Extended-release Hydrocortisone Formulations-Is There a Clinically Meaningful Benefit?

The Journal of clinical endocrinology and metabolism·2024
Same author

Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.

The Journal of clinical endocrinology and metabolism·2023
Same author

Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults.

The Journal of clinical endocrinology and metabolism·2023
Same author

High-resolution daily profiles of tissue adrenal steroids by portable automated collection.

Science translational medicine·2023
Same author

Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1.

FEBS letters·2023
Same journal

Hypophosphatasia and collagen VI-related muscular dystrophy presenting with gait disturbance and recurrent fractures.

JCEM case reports·2026
Same journal

Prolactin receptor overexpression in pregnancy-associated Cushing syndrome and functional implications.

JCEM case reports·2026
Same journal

Response to letter to the editor from Thea and Buschard: "Progression from stage 1 to stage 3 type 1 diabetes characterized by hypoglycemia".

JCEM case reports·2026
Same journal

Letter to the editor from Thea and Buschard: "Progression from stage 1 to stage 3 type 1 diabetes characterized by hypoglycemia".

JCEM case reports·2026
Same journal

Parathyroid carcinoma diagnosed after pulmonary metastases 8 years after initial parathyroidectomy.

JCEM case reports·2026
Same journal

Adipsic hypernatremia associated with hypothalamic dysfunction and sleep disorders.

JCEM case reports·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

15.0K

Immune Checkpoint Inhibitor Endocrinopathies-Insights From 3 Unusual Cases

Eystein S Husebye1,2

  • 1Department of Clinical Science, University of Bergen, Bergen N-5021, Norway.

JCEM Case Reports
|October 27, 2025
PubMed
Summary

No abstract available in PubMed .

Keywords:
autoimmune lipodystrophyhypophysitisimmune checkpoint inhibitorprimary adrenal insufficiencythyroiditistype 1 diabetes

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.4K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.8K

Related Experiment Videos

Last Updated: Jun 15, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

15.0K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.4K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.8K